Raloxifene is a widely used selective estrogen receptor modulator (SERM), prescribed globally for osteoporosis management and breast cancer risk reduction. With rising regulatory demands and analytical precision expectations, the pharmaceutical industry requires high-purity Raloxifene impurities and reference standards to support method validation, analytical research, bioequivalence studies, and formulation development.
At KarpsChem Laboratories Pvt. Ltd., we specialize in providing high-quality impurity standards backed by comprehensive characterization to meet global regulatory expectations.

KarpsChem is pleased to announce that the following Raloxifene impurities are currently available in ready stock:

• Raloxifene EP Impurity A — RLX201  |  CAS: 1159977-58-8

• Raloxifene EP Impurity B — RLX202  |  CAS: 1391054-73-1

• Raloxifene EP Impurity C — RLX203  |  CAS: 195454-31-0

• Raloxifene EP Impurity D — RLX204  |  CAS: 177744-96-6

Each impurity is supplied with COA, HPLC purity, LC-MS, NMR, IR and HRMS (where applicable) to support both R&D and QC requirements. Materials are available from milligram to gram scale and can also be produced in larger quantities under custom synthesis.

With a strong track record of working with leading pharmaceutical companies and CROs worldwide, KarpsChem ensures:
✔ Global delivery with fast courier services
✔ Best & competitive pricing in the market
✔ 24×7 data and technical support
✔ Secure packaging to maintain product integrity
✔ Reliable supply even for critical and niche impurities

If your organization requires Raloxifene impurities, working standards, metabolite standards, or custom synthesis solutions, our expert team is ready to support your analytical and formulation projects.

📩 For quotation, COA or product inquiry:
sales.karpschem@gmail.com | amitnagare@karpschem.in
📞 +91-9371639228
🌐 www.karpschem.com